Crystal and magnetic structures of RNiIn (R = Tb and Ho) have been studied using powder neutron diffraction at low temperatures. The compounds crystallize as orthorhombic crystal structures of the MnAlB type. At low temperatures, the magnetic moments localized solely on the rare earth atoms form antiferromagnetic structures. The Tb magnetic moments, equal to 8.8 (4) μ and parallel to the c axis, form a collinear magnetic structure described by the propagation vector k = [½ , ½ , ½]. This magnetic structure is stable up to the Néel temperature T = 40 K. For HoNiIn a complex, temperature-dependent magnetic structure is detected. In the temperature range 6.1-8.6 K, an incommensurate sinusoidal magnetic structure, described by the propagation vector k = [0.24, 1, 0.52] is observed, while in the temperature interval 2.2-2.5 K a square-modulated magnetic structure, related to k = [0.17,{{5} \over {6}},{{1} \over {2}}] (the component along the a axis slightly differs from the commensurate value) and its third harmonics 3k = [0.50,{{5} \over {2}},{{3} \over {2}}] is found. At 3.1-3.7 K as well as below 2 K, a coexistence of both detected magnetic structures is observed. The Ho magnetic moments remain parallel to the c axis in both the sine- and square-modulated magnetic structures. The low-temperature heat capacity data confirm a first-order transition near 3 K.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1107/S2052520623006315 | DOI Listing |
Alzheimers Dement
December 2024
EQT Life Sciences Partners, Amsterdam, 1071 DV Amsterdam, Netherlands.
Background: Alzheimer's disease (AD) trials report a high screening failure rate (potentially eligible trial candidates who do not meet inclusion/exclusion criteria during screening) due to multiple factors including stringent eligibility criteria. Here, we report the main reasons for screening failure in the 12-week screening phase of the ongoing evoke (NCT04777396) and evoke+ (NCT04777409) trials of semaglutide in early AD.
Method: Key inclusion criteria were age 55-85 years; mild cognitive impairment due to AD (Clinical Dementia Rating [CDR] global score of 0.
Alzheimers Dement
December 2024
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China.
Background: Effective early intervention of mild cognitive impairment (MCI) is the key for preventing dementia. However, there is currently no drug for MCI. As a multi-targeted neuroprotective agent, butylphthalide has been demonstrated to repair cognition in patients with vascular cognitive impairment, and has the potential to treat MCI due to Alzheimer's disease (AD).
View Article and Find Full Text PDFJ Phys Chem A
January 2025
Department of Physics, University of Northeastern, IMIT-CONICET, Av. Libertad, 5500 Corrientes, Argentina.
In this study, we worked at the CCSD/aug-cc-pVTZ level to obtain the conformers of glycine in its neutral and zwitterionic forms in the gas and water phases. We then computed the NMR properties (spin-spin coupling constants and nuclear magnetic shieldings) at the SOPPA/aug-cc-pVTZ-J level. We attempt to elucidate the apparent discrepancy arising from two previous works by Valverde et al.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.
Background: Environmental factors account for a considerable percentage of dementia cases. Studies in animal models have shown that environmental enrichment (EE; i.e.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Global Brain Health Institute (GBHI), Trinity College Dublin (TCD), Dublin, Ireland.
Background: Socioeconomic disparities (SED) influence brain health and dementia. Latin America (LA) is characterized by high SED and a disproportionate prevalence of Alzheimer's disease (AD) and frontotemporal lobe degeneration (FTLD) compared to high-income populations like the United States (US). However, the impact of SED on brain reserve across neurocognitive pathways related to aging and dementia in LA remains unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!